Semaglutide is a once-weekly subcutaneous injection
Higher amounts of the GLP-1 hormone than those used in diabetes treatment were found to suppress appetite and bring about feelings of fullness
Clinical trials show that by week 12, patients lose an average of 510 pounds, with accelerating results as doses increase
Contact your healthcare professional for assessment to determine whether the rash is medication-related and whether it is safe to continue treatment
No, microdosing below the 2.5 mg starting dose is not FDA-approved and represents off-label use without clinical validation for safety or efficacy
Post-translational modifications Crotonylation Lysine crotonylation (Kcr), a newly identified post-translational modification characterized by the addition of crotonyl groups to lysine residues, is involved in multiple physiological processes, including gene transcription, chromatin remodeling, and cell cycle [33]